Brian S. Posner's most recent trade in Arch Capital Group Ltd was a trade of 1,564 Common Shares, $.0011 par value per share done . Disclosure was reported to the exchange on May 7, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Arch Capital Group Ltd | Brian S. Posner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2025 | 1,564 | 120,104 (0%) | 0% | - | Common Shares, $.0011 par value per share | |
| Arch Capital Group Ltd | Brian S. Posner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 1,455 | 118,540 (0%) | 0% | - | Common Shares, $.0011 par value per share | |
| Arch Capital Group Ltd | Brian S. Posner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 1,714 | 117,085 (0%) | 0% | - | Common Shares, $.0011 par value per share | |
| Biogen Inc | Brian S. Posner | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 150 | 8,025 (0%) | 0% | 0 | Common Stock | |
| Arch Capital Group Ltd | Brian S. Posner | Director | Purchase of securities on an exchange or from another person at price $ 17.60 per share. | 28 Oct 2022 | 2,000 | 4,000 | - | 17.6 | 35,200 | Depositary Shares, Series G |
| Arch Capital Group Ltd | Brian S. Posner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2022 | 2,642 | 112,729 (0%) | 0% | - | Common Shares, $.0011 par value per share | |
| Arch Capital Group Ltd | Brian S. Posner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2022 | 2,642 | 115,371 (0%) | 0% | - | Common Shares, $.0011 par value per share | |
| Arch Capital Group Ltd | Brian S. Posner | Director | Purchase of securities on an exchange or from another person at price $ 19.22 per share. | 29 Apr 2022 | 2,000 | 2,000 | - | 19.2 | 38,450 | Depositary Shares, Series G |
| Arch Capital Group Ltd | Brian S. Posner | Director | Sale or transfer of securities back to the company at price $ 25.00 per share. | 30 Sep 2021 | 2,000 | 0 | - | 25 | 50,000 | Depositary Shares, Series E |
| Biogen Inc | Brian S. Posner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 775 | 8,175 (0%) | 0% | 0 | Common Stock | |
| Arch Capital Group Ltd | Brian S. Posner | Director | Sale of securities on an exchange or to another person at price $ 25.24 per share. | 14 Jun 2021 | 4,000 | 2,000 | - | 25.2 | 100,971 | Depositary Shares, Series E |
| Biogen Inc | Brian S. Posner | Director | Sale of securities on an exchange or to another person at price $ 274.17 per share. | 04 Jun 2021 | 360 | 7,400 (0%) | 0% | 274.2 | 98,701 | Common Stock |
| Arch Capital Group Ltd | Brian S. Posner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2021 | 3,143 | 110,087 (0%) | 0% | - | Common Shares, $.0011 par value per share | |
| Arch Capital Group Ltd | Brian S. Posner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2021 | 3,143 | 106,944 (0%) | 0% | - | Common Shares, $.0011 par value per share |